Global Chronic Obstructive Pulmonary Disease Therapeutics Market 2023-2028: AstraZeneca, Boehringer Ingelheim, and Novartis Spearhead Advancements
August 31, 2023 06:24 ET
|
Research and Markets
Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Chronic Obstructive Pulmonary Disease Therapeutics Market (2023-2028) by Drug Type, Distribution Channel, and Geography, Competitive Analysis,...
Global Chronic Obstructive Pulmonary Disease Therapeutics Market 2023-2028: AstraZeneca, Boehringer Ingelheim, and Novartis Spearhead Advancements
August 31, 2023 06:22 ET
|
Research and Markets
Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Chronic Obstructive Pulmonary Disease Therapeutics Market (2023-2028) by Drug Type, Distribution Channel, and Geography, Competitive Analysis,...
Global Chronic Obstructive Pulmonary Disease Therapeutics Market 2023-2028: AstraZeneca, Boehringer Ingelheim, and Novartis Spearhead Advancements
August 31, 2023 06:19 ET
|
Research and Markets
Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Chronic Obstructive Pulmonary Disease Therapeutics Market (2023-2028) by Drug Type, Distribution Channel, and Geography, Competitive Analysis,...
Anti-Asthmatics And COPD Drugs Global Market Report 2023: A $117.36 Billion Market by 2027 Featuring Novartis, Merck, GSK, Boehringer Ingelheim, AstraZeneca, Roche, Teva, Vectura, Pfizer and Abbott
February 23, 2023 07:58 ET
|
Research and Markets
Dublin, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The "Anti-Asthmatics And COPD Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.Major players in the...
The Worldwide Asthma and COPD Drugs Industry is Expected to Reach $52 Billion by 2030
May 04, 2022 08:03 ET
|
Research and Markets
Dublin, May 04, 2022 (GLOBE NEWSWIRE) -- The "Asthma and COPD Drugs Market by Diseases and Medication Class (Combination Drugs, Inhaled Corticosteroids, Short Acting Beta Agonists, Long Acting Beta...
Global Anti-Asthmatics and COPD Drugs Markets Report 2021: Top 10 in Sales are Ellipta, Symbicort, Spiriva, Advair, Nucala, Xolair, Ventolin, Pulmicort, Fasenra, Flovent
December 09, 2021 03:33 ET
|
Research and Markets
Dublin, Dec. 09, 2021 (GLOBE NEWSWIRE) -- The "Anti-Asthmatics and COPD Drugs Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth" report has been added to...
Global Anti-Asthmatics and COPD Drugs Market Report 2021 with Focus on COVID-19 Impacts - Major Players are Novartis AG, Merck & Co, GlaxoSmithKline, Boehringer Ingelheim and AstraZeneca
May 21, 2021 05:13 ET
|
Research and Markets
Dublin, May 21, 2021 (GLOBE NEWSWIRE) -- The "Anti-Asthmatics and COPD Drugs Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's...
Global Respiratory Diseases Drugs Market Report 2021: Major Players are GlaxosmithKline; AstraZeneca; Merck & Co; Novartis and Johnson & Johnson
March 03, 2021 05:58 ET
|
Research and Markets
Dublin, March 03, 2021 (GLOBE NEWSWIRE) -- The "Respiratory Diseases Drugs Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's...
World Anti-Asthmatics and COPD Drugs Market Analysis and Forecasts 2020-2030, with COVID-19 Implications and Growth Forecasts
September 15, 2020 07:38 ET
|
Research and Markets
Dublin, Sept. 15, 2020 (GLOBE NEWSWIRE) -- The "Anti-Asthmatics and COPD Drugs Global Market Report 2020-30: COVID-19 Implications and Growth" report has been added to ResearchAndMarkets.com's...